Fermenta Biotech Limited has filed a regulatory disclosure with BSE Limited regarding a general corporate update. The company submitted an application to the National Stock Exchange of India Limited (NSE) on June 16, 2026, seeking approval for listing and trading of the company's equity shares on NSE's platform through a direct listing route.
This filing is made in continuation of the previous intimation filed by the company dated May 26, 2026. The document serves to update the exchange about this development and requests that the information be taken on record.